Showing 9,621 - 9,640 results of 27,241 for search '(( 50 ((((we decrease) OR (mean decrease))) OR (a decrease)) ) OR ( 50 we decrease ))', query time: 0.87s Refine Results
  1. 9621
  2. 9622

    Table_1_What if: A retrospective reconstruction of resection cavity stereotactic radiosurgery to mimic neoadjuvant stereotactic radiosurgery.docx by Gueliz Acker (8882876)

    Published 2023
    “…In total, 62.5% of cases with an enlargement greater than 5.0 cm<sup>3</sup> were smaller tumors (pre-GTV < 15.0 cm<sup>3</sup>), whereas larger tumors greater than 25.0 cm<sup>3</sup> showed only a decrease in post-GTV. …”
  3. 9623

    Table_1_What if: A retrospective reconstruction of resection cavity stereotactic radiosurgery to mimic neoadjuvant stereotactic radiosurgery.docx by Gueliz Acker (8882876)

    Published 2023
    “…In total, 62.5% of cases with an enlargement greater than 5.0 cm<sup>3</sup> were smaller tumors (pre-GTV < 15.0 cm<sup>3</sup>), whereas larger tumors greater than 25.0 cm<sup>3</sup> showed only a decrease in post-GTV. …”
  4. 9624
  5. 9625

    The peak energy of the fitted model function of the Ti Kβ spectra as a function of the instrumental broadening by C T Chantler (557430)

    Published 2013
    “…</strong> The peak energy of the fitted model function of the Ti Kβ spectra as a function of the instrumental broadening. The measured broadening of the spectrum of 1.24(4) eV and the asymmetry of the peak leads to a shift of peak position of 0.25 eV or 50 ppm.…”
  6. 9626

    Nitric Oxide-Releasing Selective Estrogen Receptor Modulators: A Bifunctional Approach to Improve the Therapeutic Index by Nicole Bechmann (5220479)

    Published 2019
    “…We synthesized a series of NO-releasing SERMs (NO-SERMs) and the corresponding SERMs (after NO release) derived from a triaryl olefin lead. …”
  7. 9627

    Human pancreatic islet transplantation: an update and description of the establishment of a pancreatic islet isolation laboratory by Jakeline Rheinheimer (776186)

    Published 2018
    “…Recently, data published by the Collaborative Islet Transplant Registry (CITR) has revealed that approximately 50% of the patients who undergo islet transplantation are insulin independent after a 3-year follow-up. …”
  8. 9628

    Table_1_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  9. 9629

    Table_2_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  10. 9630

    Image_1_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.pdf by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  11. 9631

    Operationalising Factors That Explain the Emergence of Infectious Diseases: A Case Study of the Human Campylobacteriosis Epidemic by Norval J. C. Strachan (235193)

    Published 2013
    “…The study focused on Scotland between 1990–2012 where there was a 75% increase in reported cases that included >300% increase in the elderly and 50% decrease in young children. …”
  12. 9632

    Table_4_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  13. 9633

    Table_3_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  14. 9634

    Analysis of BCL11A gene polymorphisms and hemolysis parameters in patients with sickle-cell disease by Marilia R. Laurentino (5629814)

    Published 2018
    “…The use of HU at doses ≥ 10 mg/kg/day showed a decrease of LDH (p = 0.02), and treatment for > 50 months was linked to the reticulocyte count (p = 0.0155). …”
  15. 9635

    Table_5_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  16. 9636

    Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial by Samuel Oliveira de Afonseca (12798419)

    Published 2022
    “…Previous studies have shown that vitamin E can reduce the incidence of peripheral neuropathy by 50%. This study aimed to assess the effectiveness of vitamin E for prevention of oxaliplatin-induced peripheral neuropathy.DESIGN AND SETTINGProspective, phase II, randomized pilot study developed at a university hospital in the Greater ABC region.METHODSPatients were randomized five days before starting oxaliplatin treatment, to receive either vitamin E or placebo until the end of the chemotherapy regimen. …”
  17. 9637

    Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

    Published 2006
    “…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”
  18. 9638

    Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

    Published 2006
    “…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”
  19. 9639

    Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

    Published 2006
    “…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”
  20. 9640

    Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

    Published 2006
    “…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”